Matrixyl
- Category
- Skin & Cosmetic
- Administration routes
- Topical
- Regulatory status
- Cosmetic ingredient
What it is
A topical peptide (palmitoyl pentapeptide-4) marketed to reduce fine lines and wrinkles. That benefit has solid human support, but collagen and texture claims are only moderate, and deeper repair or pigmentation claims are unproven. It appears well tolerated with minimal absorption, though data beyond 12 weeks is limited. As a cosmetic ingredient subject to FDA safety and labeling requirements, without drug approval, quality and efficacy vary by product.
Read Full recordStudied uses & evidence
Studied uses(6)
Reduces fine lines and wrinkles
HighTwo human trials, including a 12-week randomized study, showed reduced wrinkles.
Stimulates collagen production
MediumWell established in cell and animal studies, not yet confirmed by human skin biopsy.
Improves skin texture and firmness
MediumSmall human trials suggest improvement, though results are less robust than for wrinkles.
Evidence limits
- Evidence Level
- Moderate
Matrixyl has strong in vitro evidence for stimulating collagen and ECM production. Clinical evidence includes a well-designed 93-subject RCT (Robinson et al. 2005) and a smaller 21-subject RCT (Aruan et al. 2023), both showing improvements in wrinkles. However, a 2016 systematic review (Aldag et al.) noted that clinical relevance remains limited, with some endpoints only significant under relaxed statistical thresholds. Efficacy is demonstrated at very low concentrations (3 ppm).
Benefits = confidence in the evidence: High · Medium · Low · Speculative (High requires human randomized trials for that specific benefit)
Cautions & risk summary
General cautions
Pregnancy or breastfeeding
AbsoluteNo human reproductive safety data exists for this peptide. Effects on fetal development are unknown.
Children under 18
AbsoluteNo pediatric safety data. Not recommended for use in minors.
Known hypersensitivity
AbsoluteDiscontinue immediately if allergic reaction occurs (rash, swelling, difficulty breathing).
Risk summary(7)
Risks = level of concern: High · Moderate · Low · Theoretical
Generally very well tolerated with minimal reported side effects in clinical studies
LowOccasional mild tingling reported, typically attributed to other formula ingredients rather than the peptide itself
LowNo allergic sensitization observed in repeated application studies
LowNo known systemic toxicity — topical peptide with very low systemic absorption
LowLong-term safety data beyond 12 weeks is limited in published clinical trials
LowEfficacy may vary significantly between products due to differences in formulation, concentration, and delivery systems
ModerateAs a cosmetic ingredient, manufacturing quality and concentration are not subject to pharmaceutical-grade regulation
Moderate
Further reading
- Overview in Full record
- Safety & interactions in Full record
- Research & benefits in Full record
- Regulation & availability in Full record
- Sources in Full record
- Frequently asked questions in Full record
This is educational content compiled from published research, not medical advice. Always consult a licensed healthcare provider before using any peptide. Medical disclaimer
Compiled from published research indexed through March 2026.